Five-year-old Lenna Housseini was diagnosed with a rare and aggressive cancer called Malignant Rhabdoid Tumour, which has left her with a 40% chance of survival. Her parents were denied funding for proton therapy in the U.S. due to the rarity of her condition, and they are now focusing on her well-being while navigating the limitations of current treatment options in Australia.
Loading PerspectiveSplit analysis...
